Green Pharmacy Approaches to Reduce Carbon Footprint in Healthcare: Sustainable Strategies for Pharmaceutical Manufacturing
医療におけるカーボンフットプリント削減のためのグリーンファーマシーアプローチ：持続可能な医薬品製造戦略 (AI 翻訳)
Nidhi Pimple, Rutuja Salunke, Sugandha Jha, Aayush Sankhe
🤖 gxceed AI 要約
日本語
本レビューは、医薬品製造プロセスにおけるカーボンフットプリント削減のためのグリーンファーマシー手法を包括的に概説する。グリーンケミストリー、環境に優しい医薬品開発、持続可能な生産技術（積層造形、マイクロ流体、メカノケミストリーなど）の採用が、溶媒消費、エネルギー需要、廃棄物発生を低減することを示している。また、循環型医薬品経済の実践や規制支援の重要性を強調し、事例研究としてイブプロフェンの持続可能な合成などを紹介する。
English
This review comprehensively outlines green pharmacy approaches for reducing the carbon footprint of pharmaceutical manufacturing. It discusses green chemistry, eco-friendly drug development, and sustainable production technologies (additive manufacturing, microfluidics, mechanochemistry) that reduce solvent use, energy demand, and waste. It also highlights circular economy practices and regulatory support, with case studies including sustainable ibuprofen synthesis.
Unofficial AI-generated summary based on the public title and abstract. Not an official translation.
📝 gxceed 編集解説 — Why this matters
日本のGX文脈において
日本の製薬業界は、SSBJや有報での環境情報開示が進む中、サプライチェーン全体でのGHG排出削減が課題となっている。本レビューで紹介されるグリーンファーマシー手法は、医薬品製造における具体的な排出削減策として、日本の製薬企業にとって参考になる。
In the global GX context
Globally, the healthcare sector's carbon footprint is under increasing scrutiny from frameworks like the Paris Agreement and national net-zero targets. This review provides a structured overview of green chemistry and manufacturing innovations applicable to pharmaceutical companies seeking to align with ISSB/TCFD disclosure requirements on Scope 3 emissions.
👥 読者別の含意
🔬研究者:Provides a comprehensive overview of green chemistry and manufacturing technologies for reducing pharmaceutical carbon emissions, useful for researchers in sustainable chemistry and pharmaceutical engineering.
🏢実務担当者:Corporate sustainability teams in pharmaceutical companies can use the outlined approaches (continuous processing, solvent reduction, circular economy) to identify actionable strategies for lowering manufacturing-related emissions.
🏛政策担当者:Regulators can consider the case studies and policy recommendations to support the adoption of green pharmacy practices through incentives and sustainability frameworks.
📄 Abstract（原文）
Abstract: Climate change and environmental contamination are growing worldwide issues, and the healthcare and pharmaceutical industries play a substantial role through their carbon emissions, waste production, and intensive use of resources. Drug manufacturing involves high energy consumption, solvent-based chemical synthesis, significant packaging waste, and multifaceted distribution systems, all of which heighten the environmental impact of healthcare delivery. As a result, green pharmacy has gained attention as a sustainable concept designed to reduce ecological damage while maintaining therapeutic performance. The review focuses on how green chemistry, eco-friendly drug development, and sustainable production technologies can help reduce the pharmaceutical sector’s carbon emissions. Approaches including additive manufacturing, microfluidics, mechanochemistry, spray congealing, and continuous processing help reduce solvent consumption, energy demand, and waste generation. Circular pharmaceutical economy practices, such as recycling programs, medication take-back initiatives, and eco-friendly packaging, further enhance environmental responsibility. Support from regulatory policies and international sustainability frameworks promotes wider implementation of green practices in healthcare. Case studies, including sustainable ibuprofen synthesis and enzyme-based drug production, highlight real-world applications. Collectively, embedding green pharmacy approaches within drug development, manufacturing processes, and healthcare delivery is key to lowering environmental burden and advancing sustainable healthcare. Ongoing advancements in green technologies, regulatory support, and multidisciplinary collaboration are expected to further enhance environmentally conscious pharmaceutical innovation. Keywords: Green pharmacy, sustainable pharmaceuticals, carbon footprint, green chemistry, eco-friendly drug manufacturing.
🔗 Provenance — このレコードを発見したソース
- openalex https://doi.org/10.5281/zenodo.20678235first seen 2026-06-23 05:42:14 · last seen 2026-06-23 05:43:34
🔔 こうした論文の新着を逃したくない方は キーワードアラート に登録（無料・3キーワードまで）。
gxceed は公開メタデータに基づく研究支援データセットです。要約・翻訳・解説は AI 支援で生成されています。 最終的な解釈・検証は利用者が原典資料に基づいて行うことを前提とします。